Advertisement

Enhancing diabetes care with community pharmacist-involved collaborative care model: A multi-centre randomised controlled trial

Published:February 04, 2022DOI:https://doi.org/10.1016/j.diabres.2022.109238

      Abstract

      Aim

      To evaluate the clinical and humanistic outcomes of a community pharmacist-involved collaborative care model in diabetes management.

      Methods

      This was a parallel arm, open-label, multi-centre randomized controlled trial conducted over 6 months. Subjects with type 2 diabetes, HbA1c ≥ 7.0% (53 mmol/mol) and taking ≥ 5 medications were included. Participants were randomized into intervention (collaborative care) and control groups (physician-centric care). The intervention included medication therapy management and telephonic follow-up with visits to family physicians, nurses, and dietitians. Clinical outcomes included changes in HbA1c, systolic blood pressure (SBP), lipids, and hypoglycaemic incidences. Humanistic outcomes included self-care capabilities and quality of life. Linear mixed models were constructed. Intention-to-treat analyses, with sensitivity analyses, were conducted.

      Results

      A total of 264 participants were randomized (intervention: 131, control: 133). Significantly greater reduction in HbA1c was observed in the intervention group (intervention: −0.32% (-3.52 mmol/mol) vs. control: −0.06% (-0.66 mmol/mol), p = 0.038). Changes in SBP, lipids, and incidences of hypoglycaemia were not significant over 6 months between both groups. Significantly greater improvements in self-management (p < 0.001) and quality of life (p = 0.003) were observed within the intervention group.

      Conclusion

      Partnering community pharmacists in a collaborative care team improved glycaemic control, quality of life and self-care capabilities of patients with diabetes and polypharmacy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reynolds R.
        • Dennis S.
        • Hasan I.
        • Slewa J.
        • Chen W.
        • Tian D.
        • et al.
        A systematic review of chronic disease management interventions in primary care.
        BMC Fam Pract. 2018; 19https://doi.org/10.1186/s12875-017-0692-3
        • Bauer S.
        • Nauck M.A.
        Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines–a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems.
        Diabet Med J Br Diabet Assoc. 2014; 31: 1078-1085https://doi.org/10.1111/dme.12497
        • Gnjidic D.
        • Hilmer S.N.
        • Blyth F.M.
        • Naganathan V.
        • Waite L.
        • Seibel M.J.
        • et al.
        Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
        J Clin Epidemiol. 2012; 65: 989-995https://doi.org/10.1016/j.jclinepi.2012.02.018
        • Noale M.
        • Veronese N.
        • Cavallo Perin P.
        • Pilotto A.
        • Tiengo A.
        • Crepaldi G.
        • et al.
        Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment.
        Acta Diabetol. 2016; 53: 323-330https://doi.org/10.1007/s00592-015-0790-4
        • Siaw M.Y.L.
        • Ko Y.
        • Malone D.C.
        • Tsou K.Y.K.
        • Lew Y.-J.
        • Foo D.
        • et al.
        Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
        J Clin Pharm Ther. 2017; 42: 475-482https://doi.org/10.1111/jcpt.12536
        • Abdulrhim S.H.
        • Saleh R.A.
        • Mohamed Hussain M.A.
        • Al Raey H.
        • Babiker A.H.
        • Kheir N.
        • et al.
        Impact of a Collaborative Pharmaceutical Care Service Among Patients With Diabetes in an Ambulatory Care Setting in Qatar: A Multiple Time Series Study.
        Value Health Reg Issues. 2019; 19: 45-50https://doi.org/10.1016/j.vhri.2018.12.002
        • Bukhsh A.
        • Tan X.Y.
        • Chan K.G.
        • Lee L.H.
        • Goh B.H.
        • Khan T.M.
        Effectiveness of pharmacist-led educational interventions on self-care activities and glycemic control of type 2 diabetes patients: a systematic review and meta-analysis.
        Patient Prefer Adherence. 2018; 12: 2457-2474https://doi.org/10.2147/PPA.S180256
        • Ilardo M.L.
        • Speciale A.
        The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication.
        Int J Environ Res Public Health. 2020; 17: E536https://doi.org/10.3390/ijerph17020536
        • Dhippayom T.
        • Krass I.
        Supporting self-management of type 2 diabetes: is there a role for the community pharmacist?.
        Patient Prefer Adherence. 2015; 9: 1085-1092https://doi.org/10.2147/PPA.S88071
        • Lin X.
        • Xu Y.
        • Pan X.
        • Xu J.
        • Ding Y.
        • Sun X.
        • et al.
        Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.
        Sci Rep. 2020; 10https://doi.org/10.1038/s41598-020-71908-9
      1. Thomas JS, Ong SE, Chia KS, Lee HP. A Brief History of Public Health in Singapore. In: Singapore’s Health Care System. World Scientific Series on Singapore’s 50 Years of Nation-Building. WORLD SCIENTIFIC; 2015:33-56. doi:10.1142/9789814696067_0002.

        • Burns A.
        Medication therapy management in pharmacy practice: Core elements of an MTM service model (version 2.0).
        J Am Pharm Assoc JAPhA. 2008; 48: 341-353https://doi.org/10.1331/JAPhA.2008.08514
        • Weed L.L.
        Medical records that guide and teach.
        N Engl J Med. 1968; 278: 593-600https://doi.org/10.1056/NEJM196803142781105
        • Siaw M.Y.L.
        • Ang S.W.
        • Lee J.Y.C.
        Evaluation of the Diabetes, Multidisciplinary, Experiential (DIAMANTE) Program for Retail Pharmacists: A Mixed-Method Study.
        J Contin Educ Health Prof. 2017; 37: 116-122https://doi.org/10.1097/CEH.0000000000000157
      2. Lee J. A Multidisciplinary Approach to Diabetes Continuing Education for Healthcare Professionals. CDTL Brief, First Look. http://www.cdtl.nus.edu.sg/brief/firstlook/pdf/Joyce_Lee_dec2012.pdf. Published December 2012.

        • Pratipanawatr T.
        • Satirapoj B.
        • Ongphiphadhanakul B.
        • Suwanwalaikorn S.
        • Nitiyanant W.
        Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand.
        J Diabetes Res. 2019; 2019: 1-8https://doi.org/10.1155/2019/5903820
        • Seaquist E.R.
        • Anderson J.
        • Childs B.
        • Cryer P.
        • Dagogo-Jack S.
        • Fish L.
        • et al.
        Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society.
        Diabetes Care. 2013; 36: 1384-1395https://doi.org/10.2337/dc12-2480
        • Wee H.-L.
        • Tan C.-E.
        • Goh S.-Y.
        • Li S.-C.
        Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country.
        PharmacoEconomics. 2006; 24: 673-682
        • Toobert D.J.
        • Hampson S.E.
        • Glasgow R.E.
        The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
        Diabetes Care. 2000; 23: 943-950
        • Mantovani A.
        • Byrne C.D.
        • Zheng M.H.
        • Targher G.
        Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies.
        Nutr Metab Cardiovasc Dis NMCD. 2020; 30: 1236-1248https://doi.org/10.1016/j.numecd.2020.05.014
        • Danne T.
        • Limbert C.
        • Puig Domingo M.
        • Del Prato S.
        • Renard E.
        • Choudhary P.
        • et al.
        Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future.
        Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2021; 12: 2289-2310https://doi.org/10.1007/s13300-021-01114-x
        • Michiels Y.
        • Bugnon O.
        • Chicoye A.
        • Dejager S.
        • Moisan C.
        • Allaert F.-A.
        • et al.
        Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.
        Adv Ther. 2019; 36: 1291-1303https://doi.org/10.1007/s12325-019-00957-y
        • Pousinho S.
        • Morgado M.
        • Falcão A.
        • Alves G.
        Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
        J Manag Care Spec Pharm. 2016; 22: 493-515https://doi.org/10.18553/jmcp.2016.22.5.493
        • Majumdar S.R.
        • Guirguis L.M.
        • Toth E.L.
        • Lewanczuk R.Z.
        • Lee T.K.
        • Johnson J.A.
        Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes.
        Diabetes Care. 2003; 26: 3061-3066https://doi.org/10.2337/diacare.26.11.3061
        • Shrivastava S.R.
        • Shrivastava P.S.
        • Ramasamy J.
        Role of self-care in management of diabetes mellitus.
        J Diabetes Metab Disord. 2013; 12: 14https://doi.org/10.1186/2251-6581-12-14
        • Deters M.A.
        • Laven A.
        • Castejon A.
        • Doucette W.R.
        • Ev L.S.
        • Krass I.
        • et al.
        Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components.
        Ann Pharmacother. 2018; 52: 198-211https://doi.org/10.1177/1060028017733272
      3. Carter EL, Nunlee-Bland G, Callender C. A Patient-Centric, Provider-Assisted Diabetes Telehealth Self-management Intervention for Urban Minorities. Perspect Health Inf Manag AHIMA Am Health Inf Manag Assoc. 2011;8(Winter). Accessed October 1, 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035826/.

        • McInnes S.
        • Peters K.
        • Bonney A.
        • Halcomb E.
        An integrative review of facilitators and barriers influencing collaboration and teamwork between general practitioners and nurses working in general practice.
        J Adv Nurs. 2015; 71: 1973-1985https://doi.org/10.1111/jan.12647
        • Zallman L.
        • Ibekwe L.
        • Thompson J.
        • Ross-Degnan D.
        • Oken E.
        Development of a Mapped Diabetes Community Program Guide for a Safety Net Population.
        Diabetes Educ. 2014; 40: 453-461https://doi.org/10.1177/0145721714531076
        • Kauffman Y.
        • Jonkman L.
        • Lupu A.
        • Connor S.
        Exploring the value of clinical pharmacy services for patients with diabetes in safety net settings.
        Res Soc Adm Pharm RSAP. 2013; 9: 770-776https://doi.org/10.1016/j.sapharm.2012.11.001
        • Lum Z.K.
        • Siaw M.Y.L.
        • Lee M.J.X.
        • Koh Z.
        • Zhang P.Q.
        • Eng S.K.
        • et al.
        Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes.
        Qual Life Res. 2019; 28: 3273-3279
        • Tan E.C.K.
        • Stewart K.
        • Elliott R.A.
        • George J.
        Pharmacist services provided in general practice clinics: a systematic review and meta-analysis.
        Res Soc Adm Pharm RSAP. 2014; 10: 608-622https://doi.org/10.1016/j.sapharm.2013.08.006
        • Refolo P.
        • Minacori R.
        • Mele V.
        • Sacchini D.
        • Spagnolo A.G.
        Patient-reported outcomes (PROs): the significance of using humanistic measures in clinical trial and clinical practice.
        Eur Rev Med Pharmacol Sci. 2012; 16: 1319-1323